Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-12-20
1985-11-12
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 39145
Patent
active
045527571
ABSTRACT:
A method of producing a vaccine useful in animals which comprises producing a reassortment by gene exchange from an avian influenza A virus parent and an animal influenza A virus parent and then selecting for the reassortant containing two animal surface antigen genes and six avian internal genes by temperature and antibodies.
REFERENCES:
patent: 3992522 (1976-11-01), Chanock et al.
patent: 4318903 (1982-03-01), Lobmann et al.
patent: 4338296 (1982-09-01), Lobmann et al.
patent: 4341870 (1982-07-01), Wyatt et al.
Murphy et al., Infection and Immunity, 37:1119-1126, Sep. 1982.
Murphy et al., Science, 218:1330-1332, Dec. 24, 1982.
Hinshaw et al., C.A. 99, #118900r, (1983), Virology, 1983, 128(1):260-3, Altered Tissue Tropism of Human-Avian Reassortant Influenza Viruses.
Kim et al., C.A. 87, #148423q, (1977) Izv. Akad. Naukkaz. Ssr. Ser. Biol., 1977, 15(4):29-35, Effect of Physicochemical Factors on the Enzymic Activity of Influenza Virus from Man and Birds and Their Recombinants.
Podchernyaeva, C.A. 92 #211654d, (1980).
Chanock Robert M.
Hinshaw Virginia S.
Murphy Brian R.
Webster Robert G.
Roberts, Jr. John S.
Rose Shep K.
St. Jude Children's Research Hospital
LandOfFree
Use in an animal host and precursors for vaccines utilizing avia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use in an animal host and precursors for vaccines utilizing avia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use in an animal host and precursors for vaccines utilizing avia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1879384